Timetable: Periodic safety update report (PSUR) and PSUR single assessment (PSUSA) - Advanced therapy medicinal products (ATMPs)

Questions and answers on the guideline on the environmental risk assessment of medicinal products for human use

Timetable: Safety signal - Assessment of responses to request for supplementary information (RSI) - ATMP

Questions and answers regarding co-processed excipients used in solid oral dosage forms (H & V)

EMA guidance on the use of medicinal products for treatment in case of exposure to chemical agents used as weapons of terrorism, crime, or warfare

EMA guidance on the use of medicinal products for treatment and prophylaxis in case of exposure to biological agents used as weapons of terrorism, crime or warfare

Consolidated 3-year rolling work plan for the Haematology Working Party (HAEMWP) : January 2025 - December 2027

Consolidated 3-year rolling work plan for the Oncology Working Party : January 2025 - December 2027

Draft 3-year rolling work plan for the Rheumatology and Immunology Working Party (RIWP) : 2025-2027

CAT quarterly highlights and approved ATMPs - May-July 2024